2011

VitamFero and Oniris have signed an agreement to study the efficacy of a vaccine candidate against neosporosis

VitamFero, a biotechnology firm in the Genopole cluster that develops novel vaccines to prevent specific parasitic diseases, and Oniris, an institute of higher education and specialized research, particularly in human and animal health, announced the signing of a services contract to study the efficacy of a new generation vaccine candidate against bovine (cattle) neosporosis.

[+] Previous page

Agenda

21-22 May 2012
The 5th Annual European Life Science CEO Forum: Palm Beach County Convention Center, Florida

May 31- June 1, 2012
Euro Medtech 2012: Grenoble

September 5-8, 2012
WMIC 2012 - Wolrd Molecular Imaging Congress: Dublin, Ireland

11 - 13 September 2012
World Biosimilars Congress: Jumeirah Carlton Tower, London, UK

[+] Consult the agenda

In order to receive
Genopole^® press releases^®,
please provide your coordinates
to Press Service